Guidelines for good pharmacoepidemiology practice (GPP)

doi:10.1002/pds.3891

journal article Nov 05, 2015

Guidelines for good pharmacoepidemiology practice (GPP)

Pharmacoepidemiology and Drug Safety Vol. 25 No. 1 pp. 2-10 · Wiley

View at Publisher Save 10.1002/pds.3891

Topics

No keywords indexed for this article. Browse by subject →

References

1

[1]

Austin "Guidelines of the National Heart, Lung, and Blood Institute Working Group on blood drawing, processing, and storage for genetic studies" Am J Epidemiol (1996) 10.1093/oxfordjournals.aje.a008948

Cited By

238

Effect of aclidinium bromide therapy on quality of life and symptoms of patients with chronic obstructive pulmonary disease: pooled analysis results of the Greek and Austrian ON-AIR real-world observational studies

Horst Olschewski, Nikolaos Tzanakis · 2026

BMC Pulmonary Medicine

Safety of butylphthalide and edaravone in patients with ischemic stroke: a multicenter real-world study

Shu-Xian LYU, Dong-Fang QIAN · 2023

Journal of Geriatric Cardiology

Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors

Ismaeel Yunusa, Joshua J. Gagne · 2022

JAMA Network Open

<p>Analysis of Adherence to Antihypertensive Drugs in Chinese Patients with Hypertension: A Retrospective Analysis Using the China Health Insurance Association Database </p>

Bin Cui, Zhaohui Dong · 2020

Patient Preference and Adherence

Real-World Evidence, Causal Inference, and Machine Learning

William H. Crown · 2019

Value in Health

Metrics

238

Citations

1

References

Details

Published: Nov 05, 2015
Vol/Issue: 25(1)
Pages: 2-10
License: View

Cite This Article

(2015). Guidelines for good pharmacoepidemiology practice (GPP). Pharmacoepidemiology and Drug Safety, 25(1), 2-10. https://doi.org/10.1002/pds.3891

Guidelines for good pharmacoepidemiology practice (GPP)

You May Also Like